Beschreibung
Short-chain fatty acid concentrations in stool samples are analyzed as a mechanistic outcome of the synbiotic intervention.
Figure 25
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 25: Short-chain fatty acid concentrations in stool samples are analyzed as a mechanistic outcome of the synbiotic intervention.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Short-chain fatty acid concentrations in stool samples are analyzed as a mechanistic outcome of the synbiotic intervention." /> <figcaption>Figure 25. Short-chain fatty acid concentrations in stool samples are analyzed as a mechanistic outcome of the synbiotic intervention.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
Verwandte Evidenz
B
Bifidobacterium longum für Irritable Bowel Syndrome (IBS)
B
Bewertung B · 4 Studien
Galactooligosaccharides (GOS) für Irritable Bowel Syndrome (IBS)
B
Bewertung B · 3 Studien
Lactobacillus acidophilus für Irritable Bowel Syndrome (IBS)
D
Bewertung B · 3 Studien
Fructooligosaccharides (FOS) für Irritable Bowel Syndrome (IBS)
Bewertung D · 2 Studien